Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$138 Hold
7
﹤0.01% 1069
2026
Q1
$139 Hold
7
﹤0.01% 1002
2025
Q4
$115 Hold
7
﹤0.01% 1035
2025
Q3
$97 Hold
7
﹤0.01% 1101
2025
Q2
$90 Hold
7
﹤0.01% 1033
2025
Q1
$108 Hold
7
﹤0.01% 1049
2024
Q4
$103 Hold
7
﹤0.01% 1081
2024
Q3
$112 Sell
7
-493
-99% -$8.75K ﹤0.01% 1126
2024
Q2
$9.51K Hold
500
﹤0.01% 659
2024
Q1
$9.76K Hold
500
﹤0.01% 657
2023
Q4
$10.1K Buy
+500
New +$9.82K ﹤0.01% 633

Other funds holding NOV

Glen Eagle Advisors's NOV Position: Q2 2026 in Review

Glen Eagle Advisors held its NOV (NOV) position steady in Q2 2026 at 7 shares worth $138. The position accounts for ﹤0.01% of the portfolio, ranked #1069.

Glen Eagle Advisors first reported a position in NOV in Q4 2023 and has held it in 11 quarters since. The position peaked at $10.1K in Q4 2023. 488 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • Glen Eagle Advisors held 7 shares of NOV worth $138 as of Q2 2026.
  • Glen Eagle Advisors left its NOV share count unchanged in Q2 2026.
  • NOV made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #1069 holding.
  • Glen Eagle Advisors first reported a position in NOV in Q4 2023 and has held it in 11 quarters since.
  • Glen Eagle Advisors's NOV position peaked at $10.1K in Q4 2023.
  • 488 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.